Inflammatory Reactions to Laryngeal Injection of Hyaluronic Acid Derivatives.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
ACS Applied Bio Materials Pub Date : 2025-01-01 Epub Date: 2022-08-06 DOI:10.1016/j.jvoice.2022.07.003
Alhasan N Elghouche, Obinna I Nwosu, Alexander J Jones, Timothy J Shin, Bruce H Matt, Benjamin P Anthony
{"title":"Inflammatory Reactions to Laryngeal Injection of Hyaluronic Acid Derivatives.","authors":"Alhasan N Elghouche, Obinna I Nwosu, Alexander J Jones, Timothy J Shin, Bruce H Matt, Benjamin P Anthony","doi":"10.1016/j.jvoice.2022.07.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives/hypothesis: </strong>To report the rate and describe the characteristics and management of inflammatory reactions following injection laryngoplasty with hyaluronic acid derivatives.</p><p><strong>Study design: </strong>Single institution, retrospective review.</p><p><strong>Methods: </strong>Adult and pediatric patients who underwent injection laryngoplasty with hyaluronic acid derivatives from 2013 to 2020 were identified. Demographics, indication for injection, type and volume of injected material, and use of general anesthesia were obtained. When a postoperative inflammatory response occurred, information regarding clinical presentation, timing, and subsequent management was collected.</p><p><strong>Results: </strong>A total of 464 patients who underwent 536 laryngeal injections with hyaluronic acid derivatives were included. There were 365 adult patients (median age 62 years) who underwent 431 injections and 99 pediatric patients (median age 2 years) who underwent 105 injections. The most common indications for injection were abnormal vocal fold mobility (70.3%) and aspiration (83.8%) for adult and pediatric patients, respectively. Juvéderm® was used in 449 cases (79.8% adult, 100% pediatric), and Restylane® was used in the remaining adult cases (20.2%). Procedures were mostly performed under general anesthesia (67.7% adult, 100% pediatric) with median injection volumes of 0.6 mL for adult and 0.3 mL for pediatric patients. An inflammatory reaction occurred following 3 of 536 injections (0.6%), all utilizing Juvéderm®. All three patients presented with stridor, dyspnea, and laryngeal edema within two days of injection. Each patient was admitted for observation and successfully treated with intravenous steroids and inhaled racemic epinephrine. One patient with comorbid pneumonia was intubated and required concomitant treatment with broad-spectrum antibiotics.</p><p><strong>Conclusions: </strong>Inflammatory reactions to hyaluronic acid derivatives used in injection laryngoplasty are rare but represent significant patient morbidity and can be managed with anti-inflammatory and airway stabilizing measures. Patients should be counseled appropriately regarding the risks of injection laryngoplasty with hyaluronic acid derivatives.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":"269-273"},"PeriodicalIF":4.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jvoice.2022.07.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/8/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives/hypothesis: To report the rate and describe the characteristics and management of inflammatory reactions following injection laryngoplasty with hyaluronic acid derivatives.

Study design: Single institution, retrospective review.

Methods: Adult and pediatric patients who underwent injection laryngoplasty with hyaluronic acid derivatives from 2013 to 2020 were identified. Demographics, indication for injection, type and volume of injected material, and use of general anesthesia were obtained. When a postoperative inflammatory response occurred, information regarding clinical presentation, timing, and subsequent management was collected.

Results: A total of 464 patients who underwent 536 laryngeal injections with hyaluronic acid derivatives were included. There were 365 adult patients (median age 62 years) who underwent 431 injections and 99 pediatric patients (median age 2 years) who underwent 105 injections. The most common indications for injection were abnormal vocal fold mobility (70.3%) and aspiration (83.8%) for adult and pediatric patients, respectively. Juvéderm® was used in 449 cases (79.8% adult, 100% pediatric), and Restylane® was used in the remaining adult cases (20.2%). Procedures were mostly performed under general anesthesia (67.7% adult, 100% pediatric) with median injection volumes of 0.6 mL for adult and 0.3 mL for pediatric patients. An inflammatory reaction occurred following 3 of 536 injections (0.6%), all utilizing Juvéderm®. All three patients presented with stridor, dyspnea, and laryngeal edema within two days of injection. Each patient was admitted for observation and successfully treated with intravenous steroids and inhaled racemic epinephrine. One patient with comorbid pneumonia was intubated and required concomitant treatment with broad-spectrum antibiotics.

Conclusions: Inflammatory reactions to hyaluronic acid derivatives used in injection laryngoplasty are rare but represent significant patient morbidity and can be managed with anti-inflammatory and airway stabilizing measures. Patients should be counseled appropriately regarding the risks of injection laryngoplasty with hyaluronic acid derivatives.

喉部注射透明质酸衍生物的炎症反应。
目的/假设:报告使用透明质酸衍生物注射喉成形术后炎症反应的发生率,并描述炎症反应的特征和处理方法:研究设计:单机构回顾性研究:方法:对 2013 年至 2020 年期间接受透明质酸衍生物注射喉成形术的成人和儿童患者进行鉴定。研究人员了解了患者的人口统计学特征、注射适应症、注射材料的类型和数量以及全身麻醉的使用情况。当术后出现炎症反应时,收集有关临床表现、时间和后续处理的信息:共有 464 名患者接受了 536 次喉透明质酸衍生物注射。其中,365 名成年患者(中位年龄 62 岁)接受了 431 次注射,99 名儿童患者(中位年龄 2 岁)接受了 105 次注射。成人和儿童患者最常见的注射适应症分别是声带异常活动(70.3%)和吸入(83.8%)。449 例患者(79.8% 成人,100% 儿童)使用了 Juvéderm®,其余的成人患者(20.2%)使用了 Restylane®。手术大多在全身麻醉下进行(成人占 67.7%,儿童占 100%),成人和儿童患者的中位注射量分别为 0.6 毫升和 0.3 毫升。536 次注射中有 3 次(0.6%)发生了炎症反应,均使用了 Juvéderm®。这三位患者在注射后两天内均出现了喘鸣、呼吸困难和喉头水肿。每位患者都入院接受了观察,并成功接受了静脉类固醇和吸入外消旋肾上腺素的治疗。一名患者合并肺炎,需要插管并同时使用广谱抗生素治疗:结论:注射喉成形术中使用的透明质酸衍生物引起的炎症反应非常罕见,但患者的发病率很高,可以通过抗炎和稳定气道的措施加以控制。应就使用透明质酸衍生物进行注射喉成形术的风险向患者提供适当的咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊介绍: ACS Applied Bio Materials is an interdisciplinary journal publishing original research covering all aspects of biomaterials and biointerfaces including and beyond the traditional biosensing, biomedical and therapeutic applications. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrates knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important bio applications. The journal is specifically interested in work that addresses the relationship between structure and function and assesses the stability and degradation of materials under relevant environmental and biological conditions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信